Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors
Hui Ming et al · Frontiers Media S.A · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, H. M. E. (2026). Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors. https://doi.org/10.3389/fonc.2026.1866448
MLA
al, Hui Ming et. "Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors." 2026. https://doi.org/10.3389/fonc.2026.1866448.
Chicago
al, Hui Ming et. 2026. "Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors.". https://doi.org/10.3389/fonc.2026.1866448.
Harvard
al, H. M. E. 2026, Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors, Frontiers Media S.A, available at: https://doi.org/10.3389/fonc.2026.1866448 [Accessed 30 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors
- Autor / colaboradores
- Hui Ming et al
- Editorial
- Frontiers Media S.A
- Año de publicación
- 2026
- ISSN
- 2234-943X
- ISSN
- 2234-943X
- Idioma
- eng
Materias
Explorá otros recursos relacionados a partir de estas materias.